Rationale of Using the Combination of Anti-PD-1 Antibody and Anti-IL-8 Antibody for the Pancreatic Cancer TreatmentP. Li,N. Rozich, J. Wang,J. Gai, J. Wang,Y. Xu,B. Herbst,R. Yu,S. Muth,N. Niu,K. Li,V. Fune,A. Osipov,C. L. Wolfgang,M. Lei,T. Liang,L. ZhengPANCREAS(2021)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要